Mesoblast Limited
MEOBF
$1.37
-$0.25-15.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -103.35M | -95.65M | -87.96M | -82.17M | -91.66M |
| Total Depreciation and Amortization | 4.30M | 4.49M | 4.67M | 4.48M | 5.35M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 54.90M | 46.18M | 37.46M | 27.54M | 22.93M |
| Change in Net Operating Assets | 1.61M | -510.00K | -2.63M | -3.65M | -11.97M |
| Cash from Operations | -42.54M | -45.50M | -48.46M | -53.79M | -75.35M |
| Capital Expenditure | -183.00K | -227.00K | -271.00K | -269.50K | -311.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 801.00K | 487.50K | 174.00K | 193.00K | 293.00K |
| Cash from Investing | 618.00K | 260.50K | -97.00K | -76.50K | -18.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -14.96M | -14.24M | -13.52M | -8.70M | -4.37M |
| Issuance of Common Stock | 27.04M | 46.22M | 65.41M | 96.13M | 83.28M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.70M | -9.66M | -11.63M | -12.75M | -13.63M |
| Cash from Financing | 4.39M | 22.32M | 40.25M | 74.68M | 65.28M |
| Foreign Exchange rate Adjustments | -1.99M | -1.02M | -55.00K | 644.50K | 1.21M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -39.53M | -23.94M | -8.36M | 21.46M | -8.89M |
